|
[1]
|
曾祥龙, 刘翔平, 于是(2011). 接纳与承诺疗法的理论背景、实证研究与未来发展. 心理科学进展, 19(7), 1020-1026.
|
|
[2]
|
陈盈, 胡茂荣, 何厚建等(2017). 接纳承诺疗法在青少年心理健康促进中的应用与展望. 医学与哲学, 38(20), 70-73.
|
|
[3]
|
陈卓, 祝卓宏(2019). 接纳承诺疗法在抑郁症治疗中的应用综述. 中国心理卫生杂志, 33(9), 679-683.
|
|
[4]
|
胡央儿(2014). 认知行为治疗38例焦虑症患者的临床分析. 现代实用医学, 26(12), 1487-1488.
|
|
[5]
|
迈克尔•弗斯特(2016). DSM-5鉴别诊断手册(张小梅, 张道龙, 译, pp. 223-267). 北京大学出版社.
|
|
[6]
|
王敬, 何厚健, 胡茂荣(2016). 接纳与承诺疗法的功能性语境主义解读. 医学与哲学, 37(15), 43-45.
|
|
[7]
|
武琦, 张晓娟(2017). 接纳与承诺疗法联合抗焦虑药物治疗广泛性焦虑症的临床研究. 卫生职业教育, 35(18), 140-142.
|
|
[8]
|
许熙虎, 崔云龙, 曹静, 祝卓宏(2018). 大学生经验性回避、认知融合及正念与焦虑抑郁关系. 中国公共卫生, 34(5), 741-744.
|
|
[9]
|
张慧, 黄剑波(2017). 焦虑、恐惧与这个时代的日常生活. 西南民族大学学报(人文社科版), 38(9), 6-12.
|
|
[10]
|
张婍, 王淑娟, 祝卓宏(2012). 接纳与承诺疗法的心理病理模型和治疗模式. 中国心理卫生杂志, 26(5), 377-381.
|
|
[11]
|
Atjak, J. G., Davis, M. L., Morina, N. et al. (2015). A Meta-Analysis of the Efficacy of Acceptance and Commitment Therapy for Clinically Relevant Mental and Physical Health Problems. Psychotherapy and Psychosomatics, 84, 30-36.[CrossRef] [PubMed]
|
|
[12]
|
Bandelow, B. (2020). Current and Novel Psychopharmacological Drugs for Anxiety Disorders. Advances in Experimental Medicine and Biology, 1191, 347-365.[CrossRef] [PubMed]
|
|
[13]
|
Brown, K. W., & Ryan, R. M. (2003). The Benefits of Being Present: Mindfulness and Its Role in Psychological Well-Being. Journal of Personality and Social Psychology, 84, 822-848.[CrossRef] [PubMed]
|
|
[14]
|
Craske Michelle, G., Niles Andrea, N. et al. (2014). Randomized Controlled Trial of Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for Social Phobia: Outcomes and Moderators. Journal of Consulting and Clinical Psychology, 82, 1034-1048.[CrossRef] [PubMed]
|
|
[15]
|
Cullinan, C. C., & Gaynor, S. T. (2014). Treatment of Agoraphobia in a Pregnant Woman: A Combination of Exposure and Acceptance and Commitment Therapy. Clinical Case Studies, 14, 98-114.[CrossRef]
|
|
[16]
|
Gloster, A. T., Sonntag, R., Hoyer, J. et al. (2015). Treating Treatment-Resistant Patients with Panic Disorder and Agoraphobia Using Psycho-Therapy: A Randomized Controlled Switching Trial. Psychotherapy and Psychosomatics, 84, 100-109.[CrossRef] [PubMed]
|
|
[17]
|
Hadiyan, N. M., & Kazemi, M. (2018). Effectiveness of Acceptance and Commitment Therapy (ACT) on Generalized Anxiety Disorder in Children with Type 1 Diabetes. Journal of Gorgan University of Medical Sciences, 25, 185-198.[CrossRef]
|
|
[18]
|
Harris, R. (2016). ACT, 就这么简单! 接纳承诺疗法简明实操手册(祝卓宏, 张婍, 曹慧, 等, 译, 11th ed., pp. 269-290). 机械工业出版社.
|
|
[19]
|
Hayes, S. C., Pistorello, J., & Levin, M. E. (2012). Acceptance and Commitment Therapy as a Unified Model of Behavior Change. Counseling Psychologist, 40, 976-1002.[CrossRef]
|
|
[20]
|
Hayes, S. C., Luoma, J. B., Bond, F. W. et al. (2006). Acceptance and Commitment Therapy: Model, Processes and Outcomes. Behaviour Research and Therapy, 44, 1-25.[CrossRef] [PubMed]
|
|
[21]
|
Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (1999). Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change (pp. 1-8). Guilford Press.
|
|
[22]
|
Hayes, S. C., & Strosahl, K. D. (2004). A Practical Guide to Acceptance and Commitment Therapy (pp. 396-399). Springer US.[CrossRef]
|
|
[23]
|
Hayes, S. C. (2005). Acceptance and Commitment Therapy, Relational Frame Theory, and the Third Wave of Behavioral and Cognitive Therapies. Behavior Therapy, 35, 639-665.[CrossRef]
|
|
[24]
|
Lipsker, C. W., & Morén, K. (2015). Comparing Acceptance & Commitment Therapy and traditional CBT for Social Anxiety Disorder. Uppsala University.
|
|
[25]
|
Mclean, C., & Follette, V. M. (2016). Acceptance and Commitment Therapy as a Nonpathologizing Intervention Approach for Survivors of Trauma. Journal of Trauma & Dissociation, 17, 138-150.[CrossRef] [PubMed]
|
|
[26]
|
Meuret, A. E., Twohig, M. P., Rosenfield, D. et al. (2012). Brief Acceptance and Commitment Therapy and Exposure for Panic Disorder: A Pilot Study. Cognitive and Behavioral Practice, 19, 606-618.[CrossRef]
|
|
[27]
|
Sturmey, P., & Hersen, M. (2012). Handbook of Evidence-Based Practice in Clinical Psychology (pp. 243-256). John Wiley & Sons.[CrossRef]
|
|
[28]
|
Su, H., Jiang, K. D., & Xu, Y. F. (2010). 5-Serotonin and Norepinephrine Reuptake Inhibitor Is First Line Drug for Anxiety Disorder. Chinese Journal of New Drugs and Clinical Remedies, 29, 264-269.
|
|
[29]
|
Twohig, M. P., & Levin, M. E. (2017). Acceptance and Commitment Therapy as a Treatment for Anxiety and Depression: A Review. Psychiatric Clinics of North America, 40, 751-770.[CrossRef] [PubMed]
|
|
[30]
|
Villatte, M., Vilatte, J., & Hayse, S. C. (2015). Mastering the Clinical Conversation: Language as Intervention (pp. 1-5). Guilford Publications.
|
|
[31]
|
Witlox, M., Kraaij, V. et al. (2022). Cost-Effectiveness and Cost-Utility of an Acceptance and Commitment Therapy Intervention vs. a Cognitive Behavioral Therapy Intervention for Older Adults with Anxiety Symptoms: A Randomized Controlled Trial. PLOS ONE, 17, e0262220.[CrossRef] [PubMed]
|
|
[32]
|
World Health Organization (2017). Depression and Other Common Mental Disorders: Global Health Estimates. World Health Organization.
|
|
[33]
|
Zhang, H. Y., & Li, Y. Z. (2005). Tandospirone, an Emerging Drugs for the Treatment of General Anxiety Disorders. Clinical Medicine Journal, 3, 53-57.
|